Biontech Se Sponsored Adr (BNTX), Bristol-Myers Squibb Company (BMY) announced an update on their ongoing clinical study.

Prevention and treatment advances are reducing the number of new liver cancer patients and narrowing survival gaps among ...

Tenofovir alafenamide (Vemlidy) for the initial treatment of chronic hepatitis B may confer modestly higher rates of complete ...

Pfizer Inc ($PFE) announced an update on their ongoing clinical study. PFE’s New Liver Cancer Trial: Early Signal to Watch The study, officially ...

At the Liver Meeting sponsored by the American Association for the Study of Liver Diseases, investigators presented new insights into how the immune makeup of fibrotic tissue may influence ...

Please provide your email address to receive an email when new articles are posted on . Alcohol is not the only cause of liver cancer; HBV, HCV and fatty liver disease are also risk factors. Awareness ...

Liver cancer, primarily hepatocellular carcinoma, originates in the liver, with hepatitis B and C as major risk factors. Diagnosis involves physical exams, blood tests, imaging, and possibly biopsy to ...

AMSTERDAM, the Netherlands — For patients with unresectable intermediate-stage hepatocellular carcinoma, selective internal radioembolization and standard transarterial chemoembolization provide ...

You may not be aware that most of the medicines that have been approved for treatment are rooted in nature. For example, the bark of willow trees has been called nature’s aspirin because it contains a ...

In November 2025, Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology firm specializing in therapies for primary ...